Location History:
- Kita-ku, JP (2013)
- Shizuoka, JP (2015)
- Tokyo, JP (2015 - 2023)
Company Filing History:
Years Active: 2013-2024
Title: Daisuke Kameoka: Innovator in Antibody Formulations
Introduction
Daisuke Kameoka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. With a total of 13 patents to his name, Kameoka's work has advanced the understanding and application of therapeutic antibodies.
Latest Patents
Kameoka's latest patents include innovative formulations that enhance the stability and efficacy of antibodies. One notable patent focuses on anti-IL-31RA antibody-containing formulations. This invention describes lyophilized formulations that include an IL-31 antagonist as an active ingredient, along with arginine and/or a salt thereof and sucrose and/or trehalose. Another significant patent addresses high concentration antibody-containing liquid formulations. This formulation is designed to prevent dimerization or deamidation during long-term storage, ensuring the stability of the humanized anti-IL-6 receptor antibody AMA.
Career Highlights
Throughout his career, Daisuke Kameoka has worked with leading companies in the pharmaceutical industry. He has been associated with Chugai Seiyaku Kabushiki Kaisha and Hoffmann-La Roche Inc., where he has contributed to various research and development projects. His expertise in antibody formulations has positioned him as a key player in the biotechnology sector.
Collaborations
Kameoka has collaborated with notable professionals in his field, including Toshiyuki Morichika and Yoshimi Imaeda. These collaborations have further enriched his research and have led to advancements in antibody technology.
Conclusion
Daisuke Kameoka's innovative work in antibody formulations has made a significant impact in the biotechnology industry. His patents reflect a commitment to improving therapeutic options for patients, showcasing his role as a leading inventor in this vital field.